Fulgent Genetics
FLGT
15 hedge funds and large institutions have $24.4M invested in Fulgent Genetics in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
13.39% more ownership
Funds ownership: 0% → 13.39% (+13%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$7.36M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.55M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$3.41M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.38M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$1.15M |
Top Sellers
FLGT Hedge Fund Activity: Q3 2016 in Review
15 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q3 2016, worth a combined $24.4M.
Buyers outnumbered sellers: 15 funds opened new FLGT positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $7.36M.
- 15 institutional investors held Fulgent Genetics (FLGT) as of Q3 2016, up from 0 in Q2 2016.
- Funds reported $24.4M of Fulgent Genetics stock for Q3 2016.
- 15 funds opened new Fulgent Genetics positions in Q3 2016 and 0 closed out, a net change of +15 holders.
- The largest Fulgent Genetics buyer in Q3 2016 was Cormorant Asset Management, an estimated $7.36M added.
Based on aggregated 13F filings for Q3 2016.